⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGND News
Ligand Pharmaceuticals Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XOMA Royalty Corporation (XOMA) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
XOMA
LGND
Form 8-K
sec.gov
LGNZZ
LGND
LGNYZ
LGNXZ
LGNDZ
VKTX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XOMA Royalty Corporation (XOMA) And Encourages Investors to Reach Out
accessnewswire.com
XOMA
LGND
XOMA Royalty Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of XOMA Royalty Corporation - XOMA
businesswire.com
XOMA
LGND
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation
prnewswire.com
XOMA
LGND
Form 8-K
sec.gov
LGNDZ
LGND
LGNXZ
LGNYZ
LGNZZ
XOMA
Form 8-K
sec.gov
XOMAO
XOMAP
XOMA
LGND
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
globenewswire.com
LGND
XOMA
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
globenewswire.com
LGND
XOMA
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
globenewswire.com
LGND